author-photo

Francesca Aroldi

University of Oxford

8

Papers

10

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Abstract CT136: NUC-7738, a novel ProTide transformation of 3′-deoxyadenosine, in patients with advanced solid tumors

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
CHK1 inhibition exacerbates replication stress induced by IGF blockade

2021 Oncogene
Show All
- Source
- Cite
- Save
Citations (0)
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer

2021 Cochrane Database of Systematic Reviews
Show All
- Source
- Cite
- Save
Citations (0)
422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with solid tumors

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Window of opportunity clinical trial designs to study cancer metabolism

2019 British Journal of Cancer
- Francesca Aroldi
- Simon Lord
Show All
- Source
- Cite
- Save
Citations (6)